hrs-1780
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 30, 2023 (NCT06039254)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06495931 | Phase 1 | Jul 31, 2024 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
| NCT06344936 | Phase 1 | Apr 30, 2024 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
| NCT06221059 | Phase 2 | Mar 2, 2024 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
| NCT06039254 | Phase 1 | Sep 30, 2023 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Suzhou Suncadia Biopharmaceuticals Co., Ltd. | For profit | 4 | 4 | 2 | 2023 |
1 organizations
Page 1 / 1